Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

CH Biotech R&D Co., Ltd. (6534) Income Statement

CH Biotech R&D Co., Ltd. Income Statement

Last quarter (Q2 2026), CH Biotech R&D Co., Ltd.'s total revenue was NT$459.43M, an increase of 9.26% from the same quarter last year. In Q2, CH Biotech R&D Co., Ltd.'s net income was NT$151.13M. See CH Biotech R&D Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.82BNT$ 1.64BNT$ 1.51BNT$ 1.43BNT$ 1.02B
NT$ 1.36BNT$ 1.36BNT$ 1.26BNT$ 1.13BNT$ 847.95M
NT$ 732.68MNT$ 822.52MNT$ 1.26BNT$ 623.54MNT$ 488.68M
Depreciation and AmortizationNT$ 214.12MNT$ 189.75MNT$ 165.81MNT$ 139.68MNT$ 96.65M
NT$ 837.25MNT$ 797.71MNT$ 761.56MNT$ 722.29MNT$ 470.20M
NT$ 623.13MNT$ 542.29MNT$ 565.86MNT$ 582.04MNT$ 373.44M
NT$ -54.26MNT$ 50.67MNT$ 13.07MNT$ -16.25MNT$ -13.79M
NT$ 568.87MNT$ 592.96MNT$ 578.93MNT$ 565.80MNT$ 359.65M
NT$ 463.79MNT$ 476.39MNT$ 463.29MNT$ 465.42MNT$ 291.50M
Per Share Metrics
Basic EPSNT$ 4.51NT$ 4.61NT$ 4.76NT$ 4.79NT$ 3.00
Diluted EPSNT$ 4.51NT$ 4.61NT$ 4.73NT$ 4.72NT$ 2.97
Weighted Average Shares Outstanding102.84M103.33M97.33M97.08M97.08M
Weighted Average Shares Outstanding (Diluted)102.84M103.33M97.95M98.63M98.10M

Currency in TWD

CH Biotech R&D Co., Ltd. Earnings and Revenue History

0800M1.6B2.4B10 %20 %30 %40 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin